Weekly Insights & Analysis
Consumer Private Placement and M&A Transactions Review Week Ending March 24, 2024
Strategy | Financing Transactions Private Placement / Financing Transactions PowerPollen: The company raised $8.6 million of venture funding from undisclosed investors on March 20, 2024. The company is a developer of pollination systems designed to help preserve and...
Healthcare Private Placement and M&A Transactions Review Week Ending March 24, 2024
Strategy | Financing Transactions Private Placement / Financing Transactions Capstan Therapeutics: The company raised $175 million of Series B venture funding in a deal led by RA Capital Management on March 20, 2024, putting the company's pre-money valuation at $325...
Technology Private Placement and M&A Transactions Review Week Ending March 17, 2024
Strategy | Financing Transactions Private Placement / Financing Transactions Applied Intuition: The company raised $250 million of Series E venture funding in a deal led by Porsche Ventures, Lux Capital and Elad Gil on March 12, 2024, putting the company's pre-money...
Consumer Private Placement and M&A Transactions Review Week Ending March 17, 2024
Strategy | Financing Transactions Private Placement / Financing Transactions Liquid Death: The company raised $67 million of venture funding from Live Nation Entertainment, SuRo Capital BDC and Inception Sciences on March 11, 2024, putting the company's pre-money...
Healthcare Private Placement and M&A Transactions Review Week Ending March 17, 2024
Strategy | Financing Transactions Private Placement / Financing Transactions Tubulis: The company raised EUR 128 million of Series B2 venture funding in a deal led by EQT Life Sciences and Nextech Invest on March 14, 2024. Evotec, Andera Partners, Deep Track Capital,...
A weekly digest of strategy and finance perspectives in charts, together with a review of M&A and private placement transactions by industry sector.